Cargando…

BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

SIMPLE SUMMARY: The mutational load of BRAF(V600E) in melanomas has been described as a possible prognostic biomarker but there is no information about the mutant allele frequency (MAF) variability of BRAF(V600E) within cutaneous melanomas and its potential prognostic implications. Our study suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Soria, Xavier, Vilardell, Felip, Maiques, Óscar, Barceló, Carla, Sisó, Pol, de la Rosa, Inés, Velasco, Ana, Cuevas, Dolors, Santacana, Maria, Gatius, Sònia, Matías-Guiu, Xavier, Rodrigo, Alberto, Macià, Anna, Martí, Rosa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533792/
https://www.ncbi.nlm.nih.gov/pubmed/34680222
http://dx.doi.org/10.3390/cancers13205073
_version_ 1784587398896680960
author Soria, Xavier
Vilardell, Felip
Maiques, Óscar
Barceló, Carla
Sisó, Pol
de la Rosa, Inés
Velasco, Ana
Cuevas, Dolors
Santacana, Maria
Gatius, Sònia
Matías-Guiu, Xavier
Rodrigo, Alberto
Macià, Anna
Martí, Rosa M.
author_facet Soria, Xavier
Vilardell, Felip
Maiques, Óscar
Barceló, Carla
Sisó, Pol
de la Rosa, Inés
Velasco, Ana
Cuevas, Dolors
Santacana, Maria
Gatius, Sònia
Matías-Guiu, Xavier
Rodrigo, Alberto
Macià, Anna
Martí, Rosa M.
author_sort Soria, Xavier
collection PubMed
description SIMPLE SUMMARY: The mutational load of BRAF(V600E) in melanomas has been described as a possible prognostic biomarker but there is no information about the mutant allele frequency (MAF) variability of BRAF(V600E) within cutaneous melanomas and its potential prognostic implications. Our study suggests that the variation degree of BRAF(V600E) MAF within primary cutaneous melanoma could act as a determinant in the location of primary melanomas as well as their first metastases and could influence prognostic indicators such as Breslow and mitotic indexes. BRAF(V600E) MAF variation is also related to the neoplastic cell phenotype and tumor lymphocytic infiltrate of primary tumors. For all these reasons, detection of BRAF(V600E) MAF variation could be a useful prognostic biomarker. It is worth exploring the role of BRAF(V600E) MAF variation with regards to the response of melanoma to targeted therapies. ABSTRACT: Background: Cutaneous melanoma shows high variability regarding clinicopathological presentation, evolution and prognosis. Methods: Next generation sequencing was performed to analyze hotspot mutations in different areas of primary melanomas (MMp) and their paired metastases. Clinicopathological features were evaluated depending on the degree of variation of the BRAF(V600E) mutant allele frequency (MAF) in MMp. Results: In our cohort of 14 superficial spreading, 10 nodular melanomas and 52 metastases, 17/24 (71%) melanomas had a BRAF(V600E) mutation and 5/24 (21%) had a NRAS(Q61) mutation. We observed a high variation of BRAF(V600E) MAF (H-BRAF(V600E)) in 7/17 (41%) MMp. The H-BRAF(V600E) MMp were all located on the trunk, had lower Breslow and mitotic indexes and predominantly, a first nodal metastasis. Regions with spindled tumor cells (Spin) and high lymphocytic infiltrate (HInf) were more frequent in the H-BRAF(V600E) patients (4/7; 57%), whereas regions with epithelial tumor cells (Epit) and low lymphocytic infiltrate (LInf) were predominant (6/10; 60%) and exclusive in the low BRAF(V600E) MAF variation tumors (L-BRAF(V600E)). The H-BRAF(V600E)/Spin/HInf MMp patients had better prognostic features and nodal first metastasis. Conclusions: The H-BRAF(V600E) MMp were located on the trunk, had better prognostic characteristics, such as lower Breslow and mitotic indexes as well as high lymphocytic infiltrate.
format Online
Article
Text
id pubmed-8533792
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85337922021-10-23 BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics Soria, Xavier Vilardell, Felip Maiques, Óscar Barceló, Carla Sisó, Pol de la Rosa, Inés Velasco, Ana Cuevas, Dolors Santacana, Maria Gatius, Sònia Matías-Guiu, Xavier Rodrigo, Alberto Macià, Anna Martí, Rosa M. Cancers (Basel) Article SIMPLE SUMMARY: The mutational load of BRAF(V600E) in melanomas has been described as a possible prognostic biomarker but there is no information about the mutant allele frequency (MAF) variability of BRAF(V600E) within cutaneous melanomas and its potential prognostic implications. Our study suggests that the variation degree of BRAF(V600E) MAF within primary cutaneous melanoma could act as a determinant in the location of primary melanomas as well as their first metastases and could influence prognostic indicators such as Breslow and mitotic indexes. BRAF(V600E) MAF variation is also related to the neoplastic cell phenotype and tumor lymphocytic infiltrate of primary tumors. For all these reasons, detection of BRAF(V600E) MAF variation could be a useful prognostic biomarker. It is worth exploring the role of BRAF(V600E) MAF variation with regards to the response of melanoma to targeted therapies. ABSTRACT: Background: Cutaneous melanoma shows high variability regarding clinicopathological presentation, evolution and prognosis. Methods: Next generation sequencing was performed to analyze hotspot mutations in different areas of primary melanomas (MMp) and their paired metastases. Clinicopathological features were evaluated depending on the degree of variation of the BRAF(V600E) mutant allele frequency (MAF) in MMp. Results: In our cohort of 14 superficial spreading, 10 nodular melanomas and 52 metastases, 17/24 (71%) melanomas had a BRAF(V600E) mutation and 5/24 (21%) had a NRAS(Q61) mutation. We observed a high variation of BRAF(V600E) MAF (H-BRAF(V600E)) in 7/17 (41%) MMp. The H-BRAF(V600E) MMp were all located on the trunk, had lower Breslow and mitotic indexes and predominantly, a first nodal metastasis. Regions with spindled tumor cells (Spin) and high lymphocytic infiltrate (HInf) were more frequent in the H-BRAF(V600E) patients (4/7; 57%), whereas regions with epithelial tumor cells (Epit) and low lymphocytic infiltrate (LInf) were predominant (6/10; 60%) and exclusive in the low BRAF(V600E) MAF variation tumors (L-BRAF(V600E)). The H-BRAF(V600E)/Spin/HInf MMp patients had better prognostic features and nodal first metastasis. Conclusions: The H-BRAF(V600E) MMp were located on the trunk, had better prognostic characteristics, such as lower Breslow and mitotic indexes as well as high lymphocytic infiltrate. MDPI 2021-10-11 /pmc/articles/PMC8533792/ /pubmed/34680222 http://dx.doi.org/10.3390/cancers13205073 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Soria, Xavier
Vilardell, Felip
Maiques, Óscar
Barceló, Carla
Sisó, Pol
de la Rosa, Inés
Velasco, Ana
Cuevas, Dolors
Santacana, Maria
Gatius, Sònia
Matías-Guiu, Xavier
Rodrigo, Alberto
Macià, Anna
Martí, Rosa M.
BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
title BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
title_full BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
title_fullStr BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
title_full_unstemmed BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
title_short BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
title_sort braf(v600e) mutant allele frequency (maf) influences melanoma clinicopathologic characteristics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533792/
https://www.ncbi.nlm.nih.gov/pubmed/34680222
http://dx.doi.org/10.3390/cancers13205073
work_keys_str_mv AT soriaxavier brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT vilardellfelip brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT maiquesoscar brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT barcelocarla brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT sisopol brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT delarosaines brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT velascoana brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT cuevasdolors brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT santacanamaria brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT gatiussonia brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT matiasguiuxavier brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT rodrigoalberto brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT maciaanna brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics
AT martirosam brafv600emutantallelefrequencymafinfluencesmelanomaclinicopathologiccharacteristics